These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25591788)

  • 1. Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.
    Ko CY; Chang WC; Wang JM
    J Biomed Sci; 2015 Jan; 22(1):6. PubMed ID: 25591788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ.
    Yamaguchi J; Tanaka T; Eto N; Nangaku M
    Kidney Int; 2015 Aug; 88(2):262-75. PubMed ID: 25692954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The many faces of C/EBPδ and their relevance for inflammation and cancer.
    Balamurugan K; Sterneck E
    Int J Biol Sci; 2013; 9(9):917-33. PubMed ID: 24155666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
    Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
    Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of macrophage CCAAT/enhancer binding protein delta in the pathogenesis of rheumatoid arthritis in collagen-induced arthritic mice.
    Chang LH; Huang HS; Wu PT; Jou IM; Pan MH; Chang WC; Wang DD; Wang JM
    PLoS One; 2012; 7(9):e45378. PubMed ID: 23028973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
    Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
    J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
    Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.
    Ko CY; Chang LH; Lee YC; Sterneck E; Cheng CP; Chen SH; Huang AM; Tseng JT; Wang JM
    Neurobiol Aging; 2012 Feb; 33(2):422.e11-25. PubMed ID: 21112127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein delta mediates tumor necrosis factor alpha-induced Aurora kinase C transcription and promotes genomic instability.
    Wu SR; Li CF; Hung LY; Huang AM; Tseng JT; Tsou JH; Wang JM
    J Biol Chem; 2011 Aug; 286(33):28662-28670. PubMed ID: 21715338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer binding protein (C/EBP) delta promotes the expression of PTX3 and macrophage phagocytosis during A. fumigatus infection.
    Liu L; Zhong J; Chen B; Wang W; Xi H; Su X
    J Leukoc Biol; 2022 Jun; 111(6):1225-1234. PubMed ID: 34939225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis.
    Lai PH; Wang WL; Ko CY; Lee YC; Yang WM; Shen TW; Chang WC; Wang JM
    Biochim Biophys Acta; 2008 Oct; 1783(10):1803-14. PubMed ID: 18619497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.
    Li M; Zhou W; Yuan R; Chen L; Liu T; Huang D; Hao L; Xie Y; Shao J
    FEBS Lett; 2015 Apr; 589(9):1018-25. PubMed ID: 25771860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of zinc finger protein 179 in response to CCAAT/enhancer binding protein delta conferring an antiapoptotic effect in astrocytes of Alzheimer's disease.
    Wang SM; Lee YC; Ko CY; Lai MD; Lin DY; Pao PC; Chi JY; Hsiao YW; Liu TL; Wang JM
    Mol Neurobiol; 2015 Feb; 51(1):370-82. PubMed ID: 24788683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.
    Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF
    Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
    Liu P; Cao W; Ma B; Li M; Chen K; Sideras K; Duitman JW; Sprengers D; Khe Tran TC; Ijzermans JNM; Biermann K; Verheij J; Spek CA; Kwekkeboom J; Pan Q; Peppelenbosch MP
    Carcinogenesis; 2019 Mar; 40(1):155-163. PubMed ID: 30325409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
    Chu YY; Ko CY; Wang SM; Lin PI; Wang HY; Lin WC; Wu DY; Wang LH; Wang JM
    Cell Death Dis; 2017 Nov; 8(11):e3167. PubMed ID: 29120412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy.
    Herrer I; Roselló-Lletí E; Ortega A; Tarazón E; Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Almenar L; Lago F; Sánchez-Lázaro I; González-Juanatey JR; Salvador A; Portolés M; Rivera M
    BMC Med Genomics; 2015 Mar; 8():14. PubMed ID: 25884818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability.
    Huang AM; Montagna C; Sharan S; Ni Y; Ried T; Sterneck E
    Oncogene; 2004 Feb; 23(8):1549-57. PubMed ID: 14716301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.
    Pan YC; Li CF; Ko CY; Pan MH; Chen PJ; Tseng JT; Wu WC; Chang WC; Huang AM; Sterneck E; Wang JM
    Clin Cancer Res; 2010 Dec; 16(23):5770-80. PubMed ID: 20971808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.
    Sun X; Jefferson P; Zhou Q; Angelastro JM; Greene LA
    Mol Cancer Res; 2020 Feb; 18(2):216-228. PubMed ID: 31676720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.